Literature DB >> 12757844

In vitro characterization of [3H]MethoxyPyEP, an mGluR5 selective radioligand.

Shil Patel1, Stephen M Krause, Terence Hamill, Ashok Chaudhary, Donald H Burns, Raymond A Gibson.   

Abstract

We have characterized the in vitro properties of 3-[3H]methoxy-5-(pyridin-2-ylethynyl)pyridine ([3H]MethoxyPyEP), an analogue of the mGluR(5) receptor subtype antagonist MPEP [2-methyl-6-(phenylethynyl)-pyridine], in rat tissue preparations using tissue homogenates and autoradiography. Binding of [3H]MethoxyPyEP to rat cortex, hippocampus, thalamus and cerebellum membrane preparations revealed saturable, high affinity binding (3.4 +/- 0.4 nM, n = 4 in rat cortex) to a single population of receptors in all regions studied except for cerebellum. Binding was found to be relatively insensitive to pH and insensitive to DTT. High concentrations of NEM both reduce receptor concentration and binding affinity for the radioligand. In time-course studies at room temperature k(on) and k(off) were determined as 2.9 x 10(7) M(-1) min(-1) and 0.11 min(-1) respectively. The rank order of affinities, as assessed by equilibrium competition studies, of a variety of ligands suggested binding of the radioligand selectively to mGluR5 (MPEP > trans-azetidine-2,4-dicarboxylic acid congruent with (S)-4-carboxyphenylglycine congruent with (+)MK801 congruent with CP-101,606 congruent with clozapine congruent with atropine congruent with ketanserin congruent with yohimbine congruent with benoxathian). Autoradiographic studies with [3H]MethoxyPyEP showed that binding was regioselective, with high density of binding in caudate and hippocampus, intermediate binding in thalamus and very low density in the cerebellum. These data show that [3H]MethoxyPyEP is a high affinity radioligand useful for the in vitro study of mGluR5 receptor distribution and pharmacologic properties in brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757844     DOI: 10.1016/s0024-3205(03)00272-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization.

Authors:  Shil Patel; Obinna Ndubizu; Terence Hamill; A Chaudhary; H Donald Burns; R Hargreaves; Raymond E Gibson
Journal:  Mol Imaging Biol       Date:  2005 Jul-Aug       Impact factor: 3.488

2.  Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.

Authors:  David Alagille; Herve DaCosta; Yelin Chen; Kamondanai Hemstapat; Alice Rodriguez; Ronald M Baldwin; P Jeffrey Conn; Jeffrey P Conn; Gilles D Tamagnan
Journal:  Bioorg Med Chem Lett       Date:  2011-04-20       Impact factor: 2.823

3.  Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.

Authors:  Laura N Antar; Rownak Afroz; Jason B Dictenberg; Reed C Carroll; Gary J Bassell
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

Review 4.  A Review of Molecular Imaging of Glutamate Receptors.

Authors:  Jong-Hoon Kim; János Marton; Simon Mensah Ametamey; Paul Cumming
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.